Deciphera Pharmaceuticals, Inc. Total Liabilities and Equity
Deciphera Pharmaceuticals, Inc. had Total Liabilities and Equity of $420.93 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2024-05-10
- 2024-03-31: Liabilities and Equity $420.93M.
- 2023-12-31: Liabilities and Equity $473.57M.
- 2023-09-30: Liabilities and Equity $497.84M.
- 2023-06-30: Liabilities and Equity $509.62M.
| Period end | Liabilities and Equity |
|---|---|
| 2024-03-31 | $420.93M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $473.57M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $497.84M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $509.62M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $549.02M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $454.04M 10-K · filed 2024-02-07 |
| 2022-09-30 | $475.95M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $507.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $385.46M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $429.48M 10-K · filed 2023-02-07 |
| 2021-09-30 | $483.42M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $540.57M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $595.25M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $642.43M 10-K · filed 2022-02-08 |
| 2020-09-30 | $659.67M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $686.30M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $732.93M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $622.41M 10-K · filed 2021-02-09 |
| 2019-09-30 | $649.60M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $260.01M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $269.69M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $315.56M 10-K · filed 2020-03-09 |
| 2018-09-30 | $345.92M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $368.16M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $182.14M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $199.09M 10-K · filed 2019-03-14 |
| 2016-12-31 | $58.95M 10-K · filed 2018-03-28 |